Antimicrobial resistance: a global multifaceted phenomenon

Antimicrobial resistance (AMR) is one of the most serious global public health threats in this century. The first World Health Organization (WHO) Global report on surveillance of AMR, published in April 2014, collected for the first time data from national and international surveillance networks, showing the extent of this phenomenon in many parts of the world and also the presence of large gaps in the existing surveillance. In this review, we focus on antibacterial resistance (ABR), which represents at the moment the major problem, both for the high rates of resistance observed in bacteria that cause common infections and for the complexity of the consequences of ABR. We describe the health and economic impact of ABR, the principal risk factors for its emergence and, in particular, we illustrate the highlights of four antibiotic-resistant pathogens of global concern – Staphylococcus aureus, Klebsiella pneumoniae, non-typhoidal Salmonella and Mycobacterium tuberculosis – for whom we report resistance data worldwide. Measures to control the emergence and the spread of ABR are presented.

[1]  C. Mcnulty,et al.  Don't wear me out--the public's knowledge of and attitudes to antibiotic use. , 2007, The Journal of antimicrobial chemotherapy.

[2]  L. Saiman,et al.  Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. , 2010, Clinics in perinatology.

[3]  Aamir Fazil,et al.  The global burden of nontyphoidal Salmonella gastroenteritis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Oliver,et al.  Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review. , 2011, Foodborne pathogens and disease.

[5]  G. Wang,et al.  Arsenic trioxide alleviates airway hyperresponsiveness and promotes apoptosis of CD4+ T lymphocytes: evidence for involvement of the ER stress–CHOP pathway , 2013, Irish Journal of Medical Science.

[6]  K. Kaye,et al.  Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management. , 2004, Infectious disease clinics of North America.

[7]  E. Diamadopoulos,et al.  Detection and fate of antibiotic resistant bacteria in wastewater treatment plants: a review. , 2013, Ecotoxicology and environmental safety.

[8]  S. Levy,et al.  Food Animals and Antimicrobials: Impacts on Human Health , 2011, Clinical Microbiology Reviews.

[9]  W. Zhang,et al.  Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients , 2014, Irish Journal of Medical Science (1971 -).

[10]  Conan MacDougall,et al.  Antimicrobial Stewardship Programs in Health Care Systems , 2005, Clinical Microbiology Reviews.

[11]  Yuhui,et al.  Nontyphoidal Salmonella Infection in Children with Acute Gastroenteritis: Prevalence, Serotypes, and Antimicrobial Resistance in Shanghai, China , 2014 .

[12]  Herman Goossens,et al.  Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action , 2012, Antimicrobial Resistance and Infection Control.

[13]  S. Devaraj,et al.  ANTIMICROBIAL RESISTANCE AN INTERFACE BETWEEN ANIMAL AND HUMAN DISEASES , 2014 .

[14]  P. Malani,et al.  National burden of invasive methicillin-resistant Staphylococcus aureus infection. , 2014, JAMA.

[15]  W. Yew,et al.  INVITED REVIEW SERIES: TUBERCULOSIS: CURRENT STATE OF KNOWLEDGE , 2012 .

[16]  L. Cellini,et al.  Central vascular catheter infections in a Hospital of Central Italy. , 2014, The new microbiologica.

[17]  C. Mar,et al.  Antimicrobial stewardship: What's it all about? , 2013 .

[18]  K. Lewis,et al.  A new antibiotic kills pathogens without detectable resistance , 2015, Nature.

[19]  R. Hunkler,et al.  U.S. outpatient antibiotic prescribing, 2010. , 2013, The New England journal of medicine.

[20]  L. Kalra,et al.  Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization. , 2013, American journal of infection control.

[21]  Conan MacDougall,et al.  Variability in Rates of Use of Antibacterials Among 130 US Hospitals and Risk-Adjustment Models for Interhospital Comparison , 2008, Infection Control & Hospital Epidemiology.

[22]  D. Webster,et al.  Impact of a clonal outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK. , 2011, The Journal of antimicrobial chemotherapy.

[23]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[24]  M. A. Suchard,et al.  Distinguishable Epidemics of Multidrug-Resistant Salmonella Typhimurium DT104 in Different Hosts , 2013, Science.

[25]  M. Farraj,et al.  Antimicrobial resistance in non-typhi Salmonella enterica isolated from humans and poultry in Palestine. , 2012, Journal of infection in developing countries.

[26]  Suk-kyung Lim,et al.  Emergence of Extended-Spectrum β-Lactamase (CTX-M-15 and CTX-M-14)-Producing Nontyphoid Salmonella with Reduced Susceptibility to Ciprofloxacin among Food Animals and Humans in Korea , 2011, Journal of Clinical Microbiology.

[27]  S. Davies,et al.  Antibiotic resistance: global response needed. , 2013, The Lancet. Infectious diseases.

[28]  J. Rodríguez-Baño,et al.  Clinical management of infections caused by multidrug-resistant Enterobacteriaceae , 2013, Therapeutic advances in infectious disease.

[29]  A. Pantosti,et al.  Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[30]  Lee H Harrison,et al.  National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. , 2013, JAMA internal medicine.

[31]  M. André,et al.  A survey of public knowledge and awareness related to antibiotic use and resistance in Sweden. , 2010, The Journal of antimicrobial chemotherapy.

[32]  K. Kaye,et al.  Pathogens resistant to antibacterial agents. , 2011, The Medical clinics of North America.

[33]  B. Duffy,et al.  Use of antibiotics in plant agriculture. , 2012, Revue scientifique et technique.

[34]  D. Church,et al.  Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections , 2014, Clinical Microbiology Reviews.

[35]  Hiroshi Kawaguchi,et al.  Nosocomial infections in adult intensive-care units , 2003, The Lancet.

[36]  C. Manaia,et al.  Antibiotic resistance, antimicrobial residues and bacterial community composition in urban wastewater. , 2013, Water research.

[37]  K. Rolston,et al.  The current spectrum of infection in cancer patients with chemotherapy related neutropenia , 2014, Infection.

[38]  A. Matteelli,et al.  Extensively drug-resistant tuberculosis: epidemiology and management , 2014, Clinical epidemiology.

[39]  Forum on Emerging Infections.  The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment: Workshop Summary , 2003 .

[40]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[41]  Prof. M.R Shakibaie,et al.  Antibiotic resistance patterns and extended-spectrum β-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran , 2012, Antimicrobial Resistance and Infection Control.

[42]  R. Polk,et al.  Benchmarking antimicrobial drug use in hospitals , 2012, Expert review of anti-infective therapy.

[43]  F. Aarestrup,et al.  Is It Time To Change Fluoroquinolone Breakpoints for Salmonella spp.? , 2003, Antimicrobial Agents and Chemotherapy.

[44]  Xiaohong Wang,et al.  Nontyphoidal salmonella infection in children with acute gastroenteritis: prevalence, serotypes, and antimicrobial resistance in Shanghai, China. , 2014, Foodborne pathogens and disease.

[45]  L. Pączek,et al.  Bacterial and fungal infections in the early post-transplant period after kidney transplantation: etiological agents and their susceptibility. , 2014, Transplantation proceedings.

[46]  R. Hunkler,et al.  More on U.S. outpatient antibiotic prescribing, 2010. , 2013, The New England journal of medicine.

[47]  I. Okeke,et al.  Non-prescription antimicrobial use worldwide: a systematic review. , 2011, The Lancet. Infectious diseases.

[48]  Mindy E. Flanagan,et al.  Development and Validation of Measures to Assess Prevention and Control of AMR in Hospitals , 2007, Medical care.

[49]  S. Lemon,et al.  The Resistance Phenomenon in Microbes and Infectious Disease Vectors , 2003 .

[50]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[51]  N. Petrosillo,et al.  Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections , 2013, Expert review of anti-infective therapy.

[52]  S. Kaplan,et al.  Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. , 2004, Pediatrics.

[53]  W. Schaffner,et al.  Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.